UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

American Society of Clinical Oncology position statement on obesity and cancer

Journal of clinical oncology, 2014-11, Vol.32 (31), p.3568-3574

2014

Volltextzugriff (PDF)

Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

The New England journal of medicine, 2015-03, Vol.372 (10), p.923-932

2015

Volltextzugriff (PDF)

A novel Bayesian adaptive design incorporating both primary and secondary endpoints for randomized IIB chemoprevention study of women at increased risk for breast cancer

Trials, 2022-12, Vol.23 (1), p.981-11, Article 981

2022

Volltextzugriff (PDF)

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Journal of clinical oncology, 2009-06, Vol.27 (18), p.2954-2961

2009

Volltextzugriff (PDF)

Tamoxifen: Will Less Equal More in Women with Precancerous Breast Disease?

Clinical cancer research, 2021-07, Vol.27 (13), p.3510-3511

Fabian, Carol J

2021

Volltextzugriff (PDF)

Omega-3 fatty acids for breast cancer prevention and survivorship

Breast cancer research : BCR, 2015-05, Vol.17 (1), p.62-62, Article 62

2015

Volltextzugriff (PDF)

Will a Low-Dose Option Improve Uptake of Tamoxifen for Breast Cancer Risk Reduction?

Journal of clinical oncology, 2019-07, Vol.37 (19), p.1595-1597

Fabian, Carol J

2019

Volltextzugriff (PDF)

Rapid Escalation of High-Volume Exercise during Caloric Restriction; Change in Visceral Adipose Tissue and Adipocytokines in Obese Sedentary Breast Cancer Survivors

Cancers, 2021-09, Vol.13 (19), p.4871

2021

Volltextzugriff (PDF)

Quality of Life in MAP.3 (Mammary Prevention 3): A Randomized, Placebo-Controlled Trial Evaluating Exemestane for Prevention of Breast Cancer

Journal of clinical oncology, 2014-05, Vol.32 (14), p.1427-1436

2014

Volltextzugriff (PDF)

Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007

Cancer, 2008-11, Vol.113 (10), p.2627-2637

2008

Volltextzugriff (PDF)

Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update

Journal of clinical oncology, 2019-11, Vol.37 (33), p.JCO1901472-3165

2019

Volltextzugriff (PDF)

Reduced-Frequency Endocrine Therapy and Challenges of Noninferiority Study Designs

JAMA oncology, 2023-05, Vol.9 (5), p.672

2023

Volltextzugriff (PDF)

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

The New England journal of medicine, 2011-06, Vol.364 (25), p.2381-2391

2011

Volltextzugriff (PDF)

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials

Clinical cancer research, 2017-07, Vol.23 (14), p.3628-3637

2017

Volltextzugriff (PDF)

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing

Breast cancer research and treatment, 2014-06, Vol.145 (3), p.707-714

2014

Volltextzugriff (PDF)

The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth

Breast cancer research and treatment, 2019-02, Vol.173 (3), p.545-557

2019

Volltextzugriff (PDF)

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230

JNCI : Journal of the National Cancer Institute, 2019-02, Vol.111 (2), p.210-213

2019

Volltextzugriff (PDF)

Effects of Weight Loss and Weight Regain on Circulating Biomarkers in Overweight/Obese Breast Cancer Survivors Enrolled in a Weight Loss Trial in the Rural Midwest

Cancer epidemiology, biomarkers & prevention, 2020-07, Vol.29 (7), p.1321-1328

2020

Volltextzugriff (PDF)

Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer

CA: a cancer journal for clinicians, 2023-07, Vol.73 (4), p.425-442

2023

Volltextzugriff (PDF)

Adiponectin: a risk biomarker and attractive target for chemoprevention

Journal of clinical oncology, 2012-01, Vol.30 (2), p.124-126

Fabian, Carol J

2012

Volltextzugriff (PDF)

Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial

Breast cancer research and treatment, 2017-11, Vol.166 (2), p.491-500

2017

Volltextzugriff (PDF)

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer

Breast cancer research and treatment, 2010-01, Vol.119 (1), p.111-118

2010

Volltextzugriff (PDF)

Outcomes of a weight loss intervention among rural breast cancer survivors

Breast cancer research and treatment, 2012-04, Vol.132 (2), p.631-639

2012

Volltextzugriff (PDF)

Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer

Supportive care in cancer, 2018-02, Vol.26 (2), p.575-583

2018

Volltextzugriff (PDF)

The Conundrum of Omega-3 Fatty Acids in Cancer Prevention Studies: Which One? How Much? What Biomarkers?

Cancer prevention research (Philadelphia, Pa.), 2018-04, Vol.11 (4), p.187-190

2018

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(204)

Publikationsform

Sprache

Englisch
(225)

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Humans
(126)
Life Sciences & Biomedicine
(126)
Female
(106)
Oncology
(92)
Middle Aged
(66)
Adult
(57)
Breast Cancer
(49)
Biological And Medical Sciences
(48)
Medical Sciences
(46)
Aged
(38)
Tumors
(33)
Breast Neoplasms - Pathology
(32)
Breast Neoplasms - Prevention & Control
(32)
Risk Factors
(30)
Gynecology. Andrology. Obstetrics
(25)
Mammary Gland Diseases
(25)
Male
(21)
Biomarkers
(19)
Breast Neoplasms - Metabolism
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

American Society of Clinical Oncology position statement on obesity and cancer

Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

A novel Bayesian adaptive design incorporating both primary and secondary endpoints for randomized IIB chemoprevention study of women at increased risk for breast cancer

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Tamoxifen: Will Less Equal More in Women with Precancerous Breast Disease?

Omega-3 fatty acids for breast cancer prevention and survivorship

Will a Low-Dose Option Improve Uptake of Tamoxifen for Breast Cancer Risk Reduction?

Rapid Escalation of High-Volume Exercise during Caloric Restriction; Change in Visceral Adipose Tissue and Adipocytokines in Obese Sedentary Breast Cancer Survivors

Quality of Life in MAP.3 (Mammary Prevention 3): A Randomized, Placebo-Controlled Trial Evaluating Exemestane for Prevention of Breast Cancer

Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007

Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update

Reduced-Frequency Endocrine Therapy and Challenges of Noninferiority Study Designs

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing

The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230

Effects of Weight Loss and Weight Regain on Circulating Biomarkers in Overweight/Obese Breast Cancer Survivors Enrolled in a Weight Loss Trial in the Rural Midwest

Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer

Adiponectin: a risk biomarker and attractive target for chemoprevention

Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer

Outcomes of a weight loss intervention among rural breast cancer survivors

Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer

The Conundrum of Omega-3 Fatty Acids in Cancer Prevention Studies: Which One? How Much? What Biomarkers?

Suchergebnisse filtern